Homology Medicines Inc
NASDAQ:QTTB

Watchlist Manager
Homology Medicines Inc Logo
Homology Medicines Inc
NASDAQ:QTTB
Watchlist
Price: 3.59 USD 7.49% Market Closed
Market Cap: 43.7m USD
Have any thoughts about
Homology Medicines Inc?
Write Note

Intrinsic Value

The intrinsic value of one QTTB stock under the Base Case scenario is 3.48 USD. Compared to the current market price of 3.59 USD, Homology Medicines Inc is Overvalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

QTTB Intrinsic Value
3.48 USD
Overvaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Homology Medicines Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
QTTB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for QTTB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about QTTB?
Bearish
Neutral
Bullish

Fundamental Analysis

3.59 USD
+7.49%
+7.49%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Homology Medicines Inc
US
Biotechnology
Market Cap
43.6m USD
IPO
Mar 28, 2018
Employees
224
United States of America
Market Cap
43.6m USD
Industry
Biotechnology
IPO
Mar 28, 2018
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Homology Medicines Inc

Provide an overview of the primary business activities
of Homology Medicines Inc.

What unique competitive advantages
does Homology Medicines Inc hold over its rivals?

What risks and challenges
does Homology Medicines Inc face in the near future?

Has there been any significant insider trading activity
in Homology Medicines Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Homology Medicines Inc.

Provide P/S
for Homology Medicines Inc.

Provide P/E
for Homology Medicines Inc.

Provide P/OCF
for Homology Medicines Inc.

Provide P/FCFE
for Homology Medicines Inc.

Provide P/B
for Homology Medicines Inc.

Provide EV/S
for Homology Medicines Inc.

Provide EV/GP
for Homology Medicines Inc.

Provide EV/EBITDA
for Homology Medicines Inc.

Provide EV/EBIT
for Homology Medicines Inc.

Provide EV/OCF
for Homology Medicines Inc.

Provide EV/FCFF
for Homology Medicines Inc.

Provide EV/IC
for Homology Medicines Inc.

Show me price targets
for Homology Medicines Inc made by professional analysts.

What are the Revenue projections
for Homology Medicines Inc?

How accurate were the past Revenue estimates
for Homology Medicines Inc?

What are the Net Income projections
for Homology Medicines Inc?

How accurate were the past Net Income estimates
for Homology Medicines Inc?

What are the EPS projections
for Homology Medicines Inc?

How accurate were the past EPS estimates
for Homology Medicines Inc?

What are the EBIT projections
for Homology Medicines Inc?

How accurate were the past EBIT estimates
for Homology Medicines Inc?

Compare the revenue forecasts
for Homology Medicines Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Homology Medicines Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Homology Medicines Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Homology Medicines Inc compared to its peers.

Compare the P/E ratios
of Homology Medicines Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Homology Medicines Inc with its peers.

Analyze the financial leverage
of Homology Medicines Inc compared to its main competitors.

Show all profitability ratios
for Homology Medicines Inc.

Provide ROE
for Homology Medicines Inc.

Provide ROA
for Homology Medicines Inc.

Provide ROIC
for Homology Medicines Inc.

Provide ROCE
for Homology Medicines Inc.

Provide Gross Margin
for Homology Medicines Inc.

Provide Operating Margin
for Homology Medicines Inc.

Provide Net Margin
for Homology Medicines Inc.

Provide FCF Margin
for Homology Medicines Inc.

Show all solvency ratios
for Homology Medicines Inc.

Provide D/E Ratio
for Homology Medicines Inc.

Provide D/A Ratio
for Homology Medicines Inc.

Provide Interest Coverage Ratio
for Homology Medicines Inc.

Provide Altman Z-Score Ratio
for Homology Medicines Inc.

Provide Quick Ratio
for Homology Medicines Inc.

Provide Current Ratio
for Homology Medicines Inc.

Provide Cash Ratio
for Homology Medicines Inc.

What is the historical Revenue growth
over the last 5 years for Homology Medicines Inc?

What is the historical Net Income growth
over the last 5 years for Homology Medicines Inc?

What is the current Free Cash Flow
of Homology Medicines Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Homology Medicines Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Homology Medicines Inc

Current Assets 93.9m
Cash & Short-Term Investments 89.1m
Receivables 563k
Other Current Assets 4.3m
Non-Current Assets 10.6m
Long-Term Investments 2.6m
PP&E 7.4m
Other Non-Current Assets 687k
Current Liabilities 14.4m
Accounts Payable 1.3m
Accrued Liabilities 8.9m
Other Current Liabilities 4.2m
Non-Current Liabilities 71.9m
Long-Term Debt 11.1m
Other Non-Current Liabilities 60.8m
Efficiency

Earnings Waterfall
Homology Medicines Inc

Revenue
0 USD
Operating Expenses
-54.9m USD
Operating Income
-54.9m USD
Other Expenses
5.2m USD
Net Income
-49.7m USD

Free Cash Flow Analysis
Homology Medicines Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

QTTB Profitability Score
Profitability Due Diligence

Homology Medicines Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

Homology Medicines Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

QTTB Solvency Score
Solvency Due Diligence

Homology Medicines Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
57/100
Solvency
Score

Homology Medicines Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QTTB Price Targets Summary
Homology Medicines Inc

Wall Street analysts forecast QTTB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QTTB is 88.06 USD with a low forecast of 68.68 USD and a high forecast of 105 USD.

Lowest
Price Target
68.68 USD
1 813% Upside
Average
Price Target
88.06 USD
2 353% Upside
Highest
Price Target
105 USD
2 825% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for QTTB?

Click here to dive deeper.

Dividends

Homology Medicines Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for QTTB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

QTTB Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one QTTB stock?

The intrinsic value of one QTTB stock under the Base Case scenario is 3.48 USD.

Is QTTB stock undervalued or overvalued?

Compared to the current market price of 3.59 USD, Homology Medicines Inc is Overvalued by 3%.

Back to Top